Although the importance of PD-L1/PD1 expressed in TAM is still not fully understood, targeting macrophages expressing PD-L1 in HCC can be used as a strategy to improve the effect of immunotherapy. The gene discussed is PDCD1; the disease is hepatocellular carcinoma.